CoreCap Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

CoreCap Advisors’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$20K	Buy	1,200 +200	+20%	+$3.23K	﹤0.01%	1790
2026 Q2	$15.3K	Hold	1,000	–	–	﹤0.01%	1907
2026 Q1	$14.4K	Hold	1,000	–	–	﹤0.01%	1802
2025 Q4	$15.1K	Hold	1,000	–	–	﹤0.01%	1798
2025 Q3	$14.4K	Sell	1,000 -9,000	-90%	-$128K	﹤0.01%	1788
2025 Q2	$143K	Sell	10,000 -5,700	-36%	-$81.5K	0.01%	861
2025 Q1	$234K	Buy	15,700 +9,500	+153%	+$149K	0.01%	638
2024 Q4	$89.3K	Sell	6,200 -9,500	-61%	-$147K	﹤0.01%	971
2024 Q3	$249K	Buy	+15,700	New	+$248K	0.01%	618
2024 Q2	–	Sell	-2,700	Closed	-$44.3K	–	1722
2024 Q1	$44.3K	Buy	+2,700	New	+$42.6K	﹤0.01%	1161

Other funds holding BMEZ

Chapin Davis Baltimore, Maryland $520M AUM 117.57% 1-Year Est. Return

CoreCap Advisors's BMEZ Position: Q3 2026 in Review

CoreCap Advisors increased its BlackRock Health Sciences Trust II (BMEZ) stake by 20% in Q3 2026, buying an estimated $3.23K and bringing the position to 1,200 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #1790.

CoreCap Advisors first reported a position in BMEZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $249K in Q3 2024. 2 funds tracked by Wall St. Rank hold BMEZ as of Q3 2026.

CoreCap Advisors held 1,200 shares of BlackRock Health Sciences Trust II worth $20K as of Q3 2026.
CoreCap Advisors bought 200 BlackRock Health Sciences Trust II shares in Q3 2026, an estimated $3.23K.
BlackRock Health Sciences Trust II made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1790 holding.
CoreCap Advisors first reported a position in BlackRock Health Sciences Trust II in Q1 2024 and has held it in 10 quarters since.
CoreCap Advisors's BlackRock Health Sciences Trust II position peaked at $249K in Q3 2024.
2 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.